Edition:
United States

Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

108.79USD
26 Aug 2016
Change (% chg)

$0.88 (+0.82%)
Prev Close
$107.91
Open
$107.93
Day's High
$110.13
Day's Low
$107.50
Volume
4,728,358
Avg. Vol
4,396,952
52-wk High
$128.39
52-wk Low
$93.05

KARSEN PERRY A

Institutional Holders

% Shares Owned: 79.24%
# of Holders: 1,638
Total Shares Held: 614,183,987
3 Mo. Net Change: -8,100,305
# New Positions: 93
# Closed Positions: 86
# Increased Positions: 667
# Reduced Positions: 645
# Net Buyers: 22

Officers & Directors

Name Age Since Current Position

Robert Hugin

61 2016 Executive Chairman of the Board

Jacqualyn Fouse

55 2016 President, Chief Operating Officer, Director

Mark Alles

57 2016 Chief Executive Officer, Director

Peter Kellogg

60 2014 Chief Financial Officer, Executive Vice President

Thomas Daniel

62 2016 Chairman - Celgene Research

Scott Smith

54 2014 Global President - Inflammation & Immunology

Rupert Vessey

2016 President - Research and Early Development

Gerald Masoudi

48 Executive Vice President, General Counsel and Corporate Secretary

Michael Casey

70 2007 Lead Independent Director

Michael Bonney

57 2015 Director

Julia Haller

61 2015 Director

Richard Barker

67 2012 Independent Director

Carrie Cox

58 2009 Independent Director

Michael Friedman

72 2011 Independent Director

Gilla Kaplan

69 1998 Independent Director

James Loughlin

73 2007 Independent Director

Ernest Mario

78 2007 Independent Director